Literature DB >> 20098411

MMP19 is upregulated during melanoma progression and increases invasion of melanoma cells.

Matthias Müller1, Inken M Beck, Judith Gadesmann, Nadine Karschuk, Annette Paschen, Ehrhard Proksch, Valentin Djonov, Karina Reiss, Radislav Sedlacek.   

Abstract

During the progression of cutaneous melanomas, matrix metalloproteinases (MMPs) facilitate the tumour cells to traverse the basement membrane and invade the dermis. In this study, we analysed the expression of MMP19 in the course of melanoma progression. Although MMP19 was absent in melanocytes and melanoma cells of early stages of melanoma development, its expression was strongly upregulated in the neighbouring keratinocytes that may facilitate the vertical outgrowth of melanoma cells. In contrast to early stages, MMP19 was upregulated during the vertical growth phase of melanoma and in metastases. The upregulation of MMP19 in melanoma of Clark levels IV and V correlates with that of MMP2 and also simultaneously with ceased expression of E-cadherin. To reveal whether MMP19 facilitates the invasion of melanomas, we examined adhesion and migratory capacity of selected melanoma cell lines. Melanoma cell lines with low expression of MMP19 exhibited increased adhesion to various substrates and lower migration in comparison with the cell line with higher expression of MMP19. Moreover, ectopic expression of MMP19 could restore the migratory capacity of melanoma cells with low endogenous level of MMP19. These results suggest that the increase of MMP19 expression hallmarks the progression of cutaneous melanoma and might augment melanoma growth by promoting the invasion of tumour cells.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20098411     DOI: 10.1038/modpathol.2009.183

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  16 in total

1.  Overexpression of asparagine synthetase and matrix metalloproteinase 19 confers cisplatin sensitivity in nasopharyngeal carcinoma cells.

Authors:  Ran-Yi Liu; Zizheng Dong; Jianguo Liu; Ling Zhou; Wenlin Huang; Sok Kean Khoo; Zhongfa Zhang; David Petillo; Bin Tean Teh; Chao-Nan Qian; Jian-Ting Zhang
Journal:  Mol Cancer Ther       Date:  2013-08-16       Impact factor: 6.261

2.  Matrix metalloproteinase-19 promotes metastatic behavior in vitro and is associated with increased mortality in non-small cell lung cancer.

Authors:  Guoying Yu; Jose D Herazo-Maya; Tomoko Nukui; Marjorie Romkes; Anil Parwani; Brenda M Juan-Guardela; Jennifer Robertson; Jack Gauldie; Jill M Siegfried; Naftali Kaminski; Daniel J Kass
Journal:  Am J Respir Crit Care Med       Date:  2014-10-01       Impact factor: 21.405

Review 3.  Matrix metalloproteinases in kidney homeostasis and diseases.

Authors:  Roderick J Tan; Youhua Liu
Journal:  Am J Physiol Renal Physiol       Date:  2012-04-04

4.  A critical ETV4/Twist1/Vimentin axis in Ha-RAS-induced aggressive breast cancer.

Authors:  Wuling Liu; Babu Gajendran; Klarke M Sample; Chunlin Wang; Anling Hu; Beiling Chen; Yanmei Li; Eldad Zacksenhaus; Yaacov Ben-David
Journal:  Cancer Gene Ther       Date:  2022-04-27       Impact factor: 5.987

5.  Comprehensive analysis of microglia gene and subpathway signatures for glioma prognosis and drug screening: linking microglia to glioma.

Authors:  Chunlong Zhang; Jiaxin Zhao; Wanqi Mi; Yuxi Zhang; Xiaoling Zhong; Guiyuan Tan; Feng Li; Xia Li; Yanjun Xu; Yunpeng Zhang
Journal:  J Transl Med       Date:  2022-06-21       Impact factor: 8.440

6.  A meta-analysis of transcriptome datasets characterizes malignant transformation from melanocytes and nevi to melanoma.

Authors:  Daniel Ortega-Bernal; Claudia H González-De La Rosa; Elena Arechaga-Ocampo; Miguel Angel Alvarez-Avitia; Nora Sobrevilla Moreno; Claudia Rangel-Escareño
Journal:  Oncol Lett       Date:  2018-05-31       Impact factor: 2.967

7.  Oncogenic H-ras reprograms Madin-Darby canine kidney (MDCK) cell-derived exosomal proteins following epithelial-mesenchymal transition.

Authors:  Bow J Tauro; Rommel A Mathias; David W Greening; Shashi K Gopal; Hong Ji; Eugene A Kapp; Bradley M Coleman; Andrew F Hill; Ulrike Kusebauch; Janice L Hallows; David Shteynberg; Robert L Moritz; Hong-Jian Zhu; Richard J Simpson
Journal:  Mol Cell Proteomics       Date:  2013-05-03       Impact factor: 5.911

8.  Co-expression of MMP-14 and MMP-19 predicts poor survival in human glioma.

Authors:  Liang Wang; Jun Yuan; Yanyang Tu; Xinggang Mao; Shiming He; Guoqiang Fu; Jianhai Zong; Yongsheng Zhang
Journal:  Clin Transl Oncol       Date:  2012-07-19       Impact factor: 3.405

9.  Menin represses malignant phenotypes of melanoma through regulating multiple pathways.

Authors:  Shu-Bin Gao; Zi-Jie Feng; Bin Xu; Yan Chen; Hong-Hua Zheng; Ping Yin; Xianxin Hua; Guang-Hui Jin
Journal:  J Cell Mol Med       Date:  2011-11       Impact factor: 5.310

10.  Matrix metalloproteinases: the gene expression signatures of head and neck cancer progression.

Authors:  Shinji Iizuka; Naozumi Ishimaru; Yasusei Kudo
Journal:  Cancers (Basel)       Date:  2014-02-13       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.